Found: 23
Select item for more details and to access through your institution.
Therapeutic vaccines and cancer: focus on DPX-0907.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 27, doi. 10.2147/BTT.S55196
- By:
- Publication type:
- Article
Therapeutic vaccines and cancer: focus on DPX-0907.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 27, doi. 10.2147/BTT.S55196
- By:
- Publication type:
- Article
Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 469, doi. 10.1111/bjh.15118
- By:
- Publication type:
- Article
Strategies to Enhance the Therapeutic Activity of Cancer Vaccines: Using Melanoma as a Model.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1174, p. 107, doi. 10.1111/j.1749-6632.2009.04935.x
- By:
- Publication type:
- Article
Survival of patients with transformed lymphoma in the rituximab era.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 6, p. 1007, doi. 10.1007/s00277-013-1991-y
- By:
- Publication type:
- Article
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 6, p. 771, doi. 10.1007/s00262-011-1134-z
- By:
- Publication type:
- Article
A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 6, p. 783, doi. 10.1007/s00262-011-1136-x
- By:
- Publication type:
- Article
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 345, doi. 10.1007/s002620100209
- By:
- Publication type:
- Article
Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen.
- Published in:
- Cancers, 2011, v. 3, n. 4, p. 3991, doi. 10.3390/cancers3043991
- By:
- Publication type:
- Article
PD‐L1 expression predicts efficacy in the phase II SPiReL trial with MVP‐S, pembrolizumab, and low‐dose CPA in R/R DLBCL.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 191, doi. 10.1111/ejh.13982
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. i, doi. 10.1111/ejh.14043
- By:
- Publication type:
- Article
Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
- Published in:
- Oncogene, 1998, v. 17, n. 18, p. 2339, doi. 10.1038/sj.onc.1202147
- By:
- Publication type:
- Article
Isolation of genes negatively or positively co‐expressed with human recombination activating gene 1 (RAG1)by differential display PCR (DD RT–PCR).
- Published in:
- Nucleic Acids Research, 1998, v. 26, n. 19, p. 4497, doi. 10.1093/nar/26.19.4497
- By:
- Publication type:
- Article
Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 4, p. 890, doi. 10.1002/cncr.21669
- By:
- Publication type:
- Article
Reactivation and dissemination of blastomycosis complicating hodgkin's disease: A case report and review of the literature.
- Published in:
- American Journal of Hematology, 1993, v. 43, n. 2, p. 129, doi. 10.1002/ajh.2830430211
- By:
- Publication type:
- Article
Serum‐derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of CEA‐expressing tumor cells.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 8, p. 1963, doi. 10.1002/ijc.31586
- By:
- Publication type:
- Article
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 156, doi. 10.1186/1479-5876-10-156
- By:
- Publication type:
- Article
Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with <sup>90</sup> Y ibritumomab tiuxetan in a phase II study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of central nervous system ( CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 1, p. 39, doi. 10.1111/j.1365-2141.2012.09247.x
- By:
- Publication type:
- Article
T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 1, p. 122, doi. 10.1046/j.1365-2141.2002.03240.x
- By:
- Publication type:
- Article
IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 3731, doi. 10.2147/OTT.S165411
- By:
- Publication type:
- Article
hBRAG, a novel B cell lineage cDNA encoding a type II transmembrane glycoprotein potentially involved in the regulation of recombination activating gene 1 (RAG1).
- Published in:
- European Journal of Immunology, 1998, v. 28, n. 9, p. 2839, doi. 10.1002/(SICI)1521-4141(199809)28:09<2839::AID-IMMU2839>3.0.CO;2-6
- By:
- Publication type:
- Article
Up-regulated recombination-activating gene expression in slg.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 7, p. 1501, doi. 10.1002/eji.1830230716
- By:
- Publication type:
- Article